Claims
- 1. The compound 2-�2-(dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro�4.5!decane dimaleate.
- 2. A pharmaceutical composition comprising 2-�2-(dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro�4.5!decane dimaleate and a pharmaceutically acceptable carrier or diluent.
- 3. A method of treatment of hyperlipidema which comprises administering an effective amount of 2-�2-(dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro�4.5!decane dimaleate to a patient in need of such treatment.
Parent Case Info
This application is a 371 of PCT/US96/11589 filed Jul. 11, 1996 and claims priority under 35USC 119E over Provisional Applications 60/016,066 filed Apr. 23, 1996 and 60/001,134 filed Jul. 13, 1995. The disclosure of this application is incorporated herein by reference.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/US96/11589 |
7/11/1996 |
|
|
1/12/1998 |
1/12/1998 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO97/02819 |
1/30/1997 |
|
|
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4963557 |
Badger et al. |
Oct 1990 |
|
5708019 |
Badger |
Jan 1998 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
9425024 |
Nov 1994 |
WOX |